Trial intelligence / Profile preview

Buccal dexmedetomidine and MAC of sevoflurane for LMA insertion in children

ChiCTR-IPD-17011615Phase 4Recruiting

Sponsor
Longgang District People's Hospital of Shenzhen
Start
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in inguinal hernia and penile deformity (2 arms), sponsored by Longgang District People's Hospital of Shenzhen. Primary endpoint: Response to laryngeal mask airway insertion. Started Jun 2017; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

inguinal herniapenile deformity

Beyond the preview

Go deeper on ChiCTR-IPD-17011615.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPD-17011615.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call